Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYJournal of Stroke and Cerebrovascular Diseases

Tele-based ischemic conditioning for chronic stroke: Safety, feasibility, and preliminary neurophysiological and motor effects

  1. 1Corresponding author at: Department of Physical Therapy, University of Illinois Chicago
  2. 2Brain Plasticity Laboratory, Department of Physical Therapy, University of Illinois Chicago, Chicago, IL, USA

Abstract

To examine the safety and feasibility of a two-week (seven-session) tele-based ischemic conditioning (tele-IC) intervention in individuals with chronic stroke and to explore secondary neurophysiological and motor outcomes. Methods: Ten individuals with chronic stroke (8 males; age 61.7 ± 7.3 years; time since stroke 11.5 ± 7.5 years; Fugl-Meyer Lower Extremity score 20.5 ± 6.6) completed tele-IC. The primary outcomes were safety and feasibility. Safety was assessed through monitoring of IC-related adverse events and side effects across sessions; feasibility was evaluated through screening-to-enrollment, retention, intervention adherence, tolerability, and acceptability. Secondary exploratory outcomes included corticomotor excitability, transcallosal inhibition, lower-limb strength, paretic ankle motor control, and gait speed. Outcomes were assessed before and 24 h after the intervention. Results: Across 70 tele-IC sessions, no serious adverse events occurred, and all 10 participants completed all seven sessions. Acceptability was high, including ratings for safety (4.9/5), remote assistance (4.8/5), and overall satisfaction (4.8/5). Exploratory analyses showed increased transcallosal inhibition (d_z = 0.929, p = 0.017), changes in bilateral lower-limb strength (d_z = 0.873–1.756), and shorter paretic ankle reaction time (d_z = 0.844, p = 0.049). Corticomotor excitability and gait speed did not significantly change. Conclusions: In this small, uncontrolled pilot study, synchronously supervised tele-IC was delivered with complete intervention adherence, no serious adverse events, and high participant acceptability. Exploratory secondary neurophysiological and motor findings require confirmation in larger controlled trials.

Related

  1. Remote Ischemic Conditioning Modulates Spinal Reflex Excitability in Healthy Young Adults: A Pilot Randomized Controlled Trial
    S. S. Gardas, S. Baker, M. J. Kurz +5
    medRxivPreprintAll rights reservedFull textGeneral medicinemedRxiv
  2. Remote ischemic conditioning mitigates diesel exhaust-induced pulmonary fibrosis by alleviating pulmonary inflammation and fibrogenesis
    Swati Kumari, Kaushlendra Mishra, Kanika Singh +8
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  3. Precision Oxygen Modulation in the Reperfusion Era: Conditioning and Therapeutic Strategies in Ischemic Stroke.
    Weilin Liu, Zihan Li, Zhou Sun +2
    Journal of strokePeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMC
  4. Remote ischemic conditioning plus stenting for symptomatic carotid artery stenosis (RICSICAS): rationale and design
    Jing Qiu, Wei Li, Yong-Gang Zhao +3
    Frontiers in neurologyPeer-reviewedCC BYFull textNeurologyEurope PMCCrossref
  5. Prolonged Venous Transit on MRI as a Prognostic Biomarker in Acute Ischemic Stroke: A Feasibility Study
    Derek A. Tsang, Mona Gad, Andrew Cho +10
    AJNR: American Journal of NeuroradiologyPeer-reviewedLicence not statedFull textNeurologyPMC
BibTeX
@article{madhavan2026telebased,
  title = {{Tele-based ischemic conditioning for chronic stroke: Safety, feasibility, and preliminary neurophysiological and motor effects}},
  author = {Sangeetha Madhavan and Mark Cummings and Danny Mathew},
  journal = {Journal of Stroke and Cerebrovascular Diseases},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jstrokecerebrovasdis.2026.108772},
  url = {https://doi.org/10.1016/j.jstrokecerebrovasdis.2026.108772},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Tele-based ischemic conditioning for chronic stroke: Safety, feasibility, and preliminary neurophysiological and motor effects
AU  - Sangeetha Madhavan
AU  - Mark Cummings
AU  - Danny Mathew
PY  - 2026
DA  - 2026/10/30
JO  - Journal of Stroke and Cerebrovascular Diseases
DO  - 10.1016/j.jstrokecerebrovasdis.2026.108772
UR  - https://doi.org/10.1016/j.jstrokecerebrovasdis.2026.108772
AB  - To examine the safety and feasibility of a two-week (seven-session) tele-based ischemic conditioning (tele-IC) intervention in individuals with chronic stroke and to explore secondary neurophysiological and motor outcomes. Methods: Ten individuals with chronic stroke (8 males; age 61.7 ± 7.3 years; time since stroke 11.5 ± 7.5 years; Fugl-Meyer Lower Extremity score 20.5 ± 6.6) completed tele-IC. The primary outcomes were safety and feasibility. Safety was assessed through monitoring of IC-related adverse events and side effects across sessions; feasibility was evaluated through screening-to-enrollment, retention, intervention adherence, tolerability, and acceptability. Secondary exploratory outcomes included corticomotor excitability, transcallosal inhibition, lower-limb strength, paretic ankle motor control, and gait speed. Outcomes were assessed before and 24 h after the intervention. Results: Across 70 tele-IC sessions, no serious adverse events occurred, and all 10 participants completed all seven sessions. Acceptability was high, including ratings for safety (4.9/5), remote assistance (4.8/5), and overall satisfaction (4.8/5). Exploratory analyses showed increased transcallosal inhibition (d_z = 0.929, p = 0.017), changes in bilateral lower-limb strength (d_z = 0.873–1.756), and shorter paretic ankle reaction time (d_z = 0.844, p = 0.049). Corticomotor excitability and gait speed did not significantly change. Conclusions: In this small, uncontrolled pilot study, synchronously supervised tele-IC was delivered with complete intervention adherence, no serious adverse events, and high participant acceptability. Exploratory secondary neurophysiological and motor findings require confirmation in larger controlled trials.
SN  - 1532-8511
ER  -